This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Momenta Pharmaceuticals Inc (MNTA)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 29.77M 52.99M 49.24M 100.68M
Receivables 16.51M 11.61M 30.94M 54.48M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 5.26M
Total Current Assets 265.59M 357.17M 399.42M 203.31M
Property, Plant & Equipment, Gross 58.61M 50.05M 34.74M 27.22M
Accumulated Depreciation & Depletion 33.91M 27.67M 21.42M 18.22M
Property, Plant & Equipment, Net 24.70M 22.38M 13.33M 9.00M
Intangibles 5.65M 6.71M 7.77M 2.49M
Other Non-Current Assets 20.88M 20.37M 389.00K 12.77M
Total Non-Current Assets 51.22M 49.46M 21.49M 24.26M
Liabilities & Shareholder Equity
Total Assets 316.82M 406.63M 420.91M 227.57M
Accounts Payable 6.31M 3.58M 4.71M 4.39M
Short Term Debt 0.00 0.00 0.00 1.99M
Other Current Liabilities 496.00K 514.00K 32.00K 23.00K
Total Current Liabilities 21.94M 18.16M 16.03M 17.65M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 144.00K 0.00
Other Non-Current Liabilities 25.04M 27.98M 1.66M 3.81M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 25.04M 27.98M 1.80M 3.81M
Total Liabilities 46.98M 46.14M 17.83M 21.47M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 269.84M 360.49M 403.08M 206.10M
Common Par 5.00K 5.00K 5.00K 5.00K
Additional Paid In Capital 540.27M 522.42M 506.56M 489.87M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -270.46M -162.05M -103.40M -283.76M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 25.00K 111.00K -81.00K -16.00K
Total Capitalization 269.84M 360.49M 403.08M 206.10M
Total Equity 269.84M 360.49M 403.08M 206.10M
Total Liabilities & Stock Equity 316.82M 406.63M 420.91M 227.57M
Total Common Shares Outstanding 52.36M 51.71M 51.28M 49.75M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 50.91M 50.41M 49.85M 44.63M
Diluted Weighted Shares Outstanding 50.91M 50.41M 50.82M 45.94M
Number of Employees 269 247 197 170
Number of Part-Time Employees 0 0 0 0

MNTA Momenta Pharmaceuticals Inc

Analysts Ratings for MNTA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 1 0 0 0

Brokerage Partners

MNTA Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs